Cotización Q32 Bio - QTTB

Discusiones en tiempo real e ideas comerciales: opere con confianza con nuestra poderosa plataforma.

Premium

Último Precio

3.23

Postura de Compra

3.02

Postura de Venta

3.25

Volume Operado de la Acción

125,829

3.04 Rango del Día 3.25

2.95 Rango de 52 semanas 53.79

Precio Anterior

3.02

Precio de Apertura

3.04

Hora

100

3.23

(formt)

Última hora de negociación

Volumen promedio (3 m)

403,067

Volumen financiero

US$ 396,264

Precio Promedio Ponderado

3.1492

Flujo General

Pesimista

Prima Neta

-135k

Calls / Puts

0.00%

Comp. / Vent.

0.00%

OTM / ITM

0.00%

Sweeps Ratio

0.00%

Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference

Q32 Bio to Participate in Oppenheimer's 35th Annual Healthcare Life Sciences Conference PR Newswire WALTHAM, Mass., Feb. 4, 2025 WALTHAM, Mass., Feb. 4, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq:...

Form 8-K - Current report

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 8-K - Current report

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program

Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program PR Newswire WALTHAM, Mass., Dec. 10, 2024 -- SIGNAL-AA demonstrated encouraging...

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update

Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update PR Newswire WALTHAM, Mass., Nov. 7, 2024 -- Bempikibart Phase 2 topline results in atopic dermatitis (AD) and...

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference

Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference PR Newswire WALTHAM, Mass., Nov. 5, 2024 WALTHAM, Mass., Nov. 5, 2024 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB...

Período †	Variación(Ptos)	Variación %	Apertura	Precio Máximo	Precio Mínimo	Avg. Vol. diario	Precio Promedio Ponderado
1	-0.04	-1.22324159021	3.27	3.47	2.95	217383	3.11392049	CS
4	-0.5124	-13.6917486105	3.7424	3.95	2.95	214182	3.24730634	CS
12	-41.77	-92.8222222222	45	47.3153	2.95	403067	6.85170453	CS
26	-31.47	-90.6916426513	34.7	53.79	2.95	234903	16.30305637	CS
52	-13.01	-80.1108374384	16.24	53.79	2.95	164929	17.76974781	CS
156	-13.01	-80.1108374384	16.24	53.79	2.95	164929	17.76974781	CS
260	-13.01	-80.1108374384	16.24	53.79	2.95	164929	17.76974781	CS

QTTB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Q32 Bio?

El precio actual de las acciones de Q32 Bio es US$ 3.23

¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Q32 Bio?

Q32 Bio ha negociado en un rango de US$ 2.95 a US$ 53.79 durante el último año

Volumen
% Mayores Alzas
% Mayores Bajas

Símbolo	Precio	Vol.
CAPTCaptiVision Inc	US$ 1.024 (133.26%)	246M
QNTMQuantum Biopharma Ltd	US$ 6.70 (110.69%)	78.56M
LTRYLottery com Inc	US$ 0.58 (85.90%)	129.21M
CPIXCumberland Pharmaceutical Inc	US$ 3.7801 (77.47%)	18.49M
INKTMiNK Therapeutics Inc	US$ 12.08 (53.69%)	350.86k
OMGAOmega Therapeutics Inc	US$ 0.1473 (-69.25%)	11.71M
VIRXViracta Therapeutics Inc	US$ 0.0352 (-54.76%)	6.33M
CYNCYNGN Inc	US$ 0.0708 (-39.44%)	137.42M
UPCUniverse Pharmaceuticals Inc	US$ 0.2663 (-36.20%)	1.9M
CSAICloudastructure Inc	US$ 12.98 (-31.68%)	57.03k
NVDANVIDIA Corporation	US$ 118.65 (1.71%)	256.77M
CAPTCaptiVision Inc	US$ 1.024 (133.26%)	246M
PLTRPalantir Technologies Inc	US$ 103.83 (23.99%)	230.5M
RGTIRigetti Computing Inc	US$ 13.71 (1.78%)	159.64M
TNXPTonix Pharmaceuticals Holding Corporation	US$ 0.1518 (-22.11%)	142.77M